Oral Glucose Stimulation in Normal-weight and Obese Volunteers
NCT01875575 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2013-06-12
Summary
The objective of this study is to examine gastric emptying and satiety hormones after oral glucose stimulation in 2 different concentrations in normal-weight and obese patients.
Conditions
- Endocrine System Diseases
Interventions
- DIETARY_SUPPLEMENT
-
Placebo
- DIETARY_SUPPLEMENT
-
Glucose 25g
- DIETARY_SUPPLEMENT
-
Glucose 10g
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Christoph Beglinger, Prof · University Hospital, Basel, Switzerland
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2013-04-30
- Completion
- 2013-04-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176760 ·Status: UNKNOWN ·Phase: NA
-
Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
NCT01185119 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Anatomical Location, Cellular Origin and Molecular Basis of Gut-derived Glucagon Secretion
NCT03181191 ·Status: COMPLETED ·Phase: NA
-
Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?
NCT03954873 ·Status: COMPLETED ·Phase: NA
-
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740 ·Status: UNKNOWN ·Phase: NA
-
Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome
NCT00673751 ·Status: UNKNOWN ·Phase: NA
-
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
NCT01507597 ·Status: COMPLETED ·Phase: NA
-
The Glucagonotropic Effect of Amino Acids in Humans
NCT05954923 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Receptor Expression in CHI
NCT03768518 ·Status: UNKNOWN
-
Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion
NCT01176708 ·Status: UNKNOWN ·Phase: NA
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans
NCT00876213 ·Status: COMPLETED
-
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
NCT01194479 ·Status: COMPLETED ·Phase: NA
-
Effects of Oral vs Intravenous Glucose Administration on Novel Candidates of Energy Regulation
NCT04888325 ·Status: COMPLETED ·Phase: NA
-
Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176890 ·Status: UNKNOWN ·Phase: NA
-
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 ·Status: UNKNOWN ·Phase: NA
-
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
NCT00612625 ·Status: COMPLETED ·Phase: NA
-
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
NCT03139305 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.
NCT04186026 ·Status: UNKNOWN ·Phase: NA
-
Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
NCT04687514 ·Status: COMPLETED ·Phase: PHASE2
-
How is Glycogen Supercompensation Regulated in Human Skeletal Muscle
NCT03458741 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Signaling in Truncally Vagotomized Subjects
NCT02940184 ·Status: UNKNOWN ·Phase: NA
-
The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes
NCT03734718 ·Status: COMPLETED ·Phase: NA
-
Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism
NCT00999271 ·Status: COMPLETED
-
The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU
NCT02337556 ·Status: COMPLETED ·Phase: NA